STEMI (ST elevation myocardial infarction), Left ventricular thrombosis
Conditions
Brief summary
It is defined a binary composite primary endpoint consisting of incomplete thrombus resolution after three months of treatment and the 3-month incidence of a new symptomatic (clinical ischemic stroke) or asymptomatic (“silent” brain infraction detected by screening MRI) brain infarction.
Detailed description
Prevalence of complete thrombus resolution after 3 months of anticoagulant treatment with dabigatran or phenprocoumon., Cumulative 3-month incidence of symptomatic or asymptomatic brain infarction., Cumulative 12-month incidence of symptomatic or asymptomatic brain infarction., Cumulative incidence of bleeding events using the BARC 2,3,5 bleeding criteria during active study (3 months) and 1 year follow up .
Interventions
DRUGCLOPIDOGREL
DRUGACETYLSALICYLIC ACID
DRUGMARCOUMAR - Tabletten
Sponsors
Medical University Of Graz
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is defined a binary composite primary endpoint consisting of incomplete thrombus resolution after three months of treatment and the 3-month incidence of a new symptomatic (clinical ischemic stroke) or asymptomatic (“silent” brain infraction detected by screening MRI) brain infarction. | — |
Secondary
| Measure | Time frame |
|---|---|
| Prevalence of complete thrombus resolution after 3 months of anticoagulant treatment with dabigatran or phenprocoumon., Cumulative 3-month incidence of symptomatic or asymptomatic brain infarction., Cumulative 12-month incidence of symptomatic or asymptomatic brain infarction., Cumulative incidence of bleeding events using the BARC 2,3,5 bleeding criteria during active study (3 months) and 1 year follow up . | — |
Countries
Austria
Outcome results
None listed